Abstract

2,3-dihydroxy-2-methylbutyric acid, also known as 2,3-dimethylglyceric acid, constitutes the acyl and/or the alcoholic moiety of many bioactive natural esters. Herein, we describe a chemoenzymatic methodology which gives access to all the four possible stereoisomers of the 2,3-dimethylglyceric acid ethyl ester. The racemic ethyl α-acetolactate, produced by the N-heterocycle carbene (NHC)-catalyzed coupling of ethyl pyruvate and methylacetoin was employed as the starting material. The racemic mixture was resolved through (S)-selective reductions, promoted by the acetylacetoin reductase (AAR) affording the resulting ethyl (2R,3S)-2,3-dimethylglycerate; the isolated remaining (S)-ethyl α-acetolactate was successively treated with baker’s yeast to obtain the corresponding (2S,3S) stereoisomer. syn-2,3-Dimethylgliceric acid ethyl ester afforded by reducing the rac-α-acetolactate with NaBH4 in the presence of ZnCl2 was kinetically resolved through selective acetylation with lipase B from Candida antarctica (CAL-B) and vinyl acetate to access to (2S,3R) stereoisomer. Finally, the (2R,3R) stereoisomer, was prepared by C3 epimerization of the (2R,3S) stereoisomer recovered from the above kinetic resolution, achieved through the TEMPO-mediated oxidation, followed by the reduction of the produced ketone with NaBH4. The resulting 2,3-dimethylglycertate enriched in the (2R,3R) stereoisomer was submitted to stereospecicific acetylation with vinyl acetate and CAL-B in order to separate the major stereoisomer. The entire procedure enabled conversion of the racemic α-acetolactate into the four enantiopure stereoisomers of the ethyl 2,3-dihydroxy-2-methylbutyrate with the following overall yields: 42% for the (2R,3S), 40% for the (2S,3S), 42% for the (2S,3R) and 20% for the (2R,3R).

Highlights

  • The curative effects of traditional pharmaceutics are frequently related to the activity of secondary metabolites produced by plants or microorganisms

  • As above mentioned, we recently reported the enzymatic synthesis of the (2R,3S)-2,3-dimethylglygeric acid ethyl ester through the enzymatic reduction of the ethyl (R)-α-acetolactate previously prepared by benzoin-type condensation of methylacetoin and ethyl pyruvate catalyzed by a thiamine diphosphate-dependent lyase [13]

  • Within a previous study we reported the enzymatic synthesis of optically pure ethyl ester of the (2R,3S)-2,3-dimethylglyceric acid [13]

Read more

Summary

Introduction

The curative effects of traditional pharmaceutics are frequently related to the activity of secondary metabolites produced by plants or microorganisms. From an economic and environmental point of view, a sustainable industrial synthesis of these metabolites should require highly efficient and selective reactions so as to reduce the number of steps, simplify the purification procedures and reduce waste formation and energy costs [5]. From this perspective, biocatalysis nowadays offers a broad range of accessible enzymes to Catalysts 2021, 11, 1440 simplify the purification procedures and reduce waste formation and energy costs [5]. Biocatalysis nowadays offers a broad range of perform challenging reactions with excellent resultsreactions in terms with of yield and selectivity accessible enzymes to perform challenging excellent results in[6,7,8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call